European Academy of Otology and Neurotology (EAONO)转发了
KEYNOTE SPEAKER INTRODUCTION Anu Sharma, Professor and Associate Chair in the Department of Speech Language and Hearing Science and Fellow in the Institute for Cognitive Science Studies and in the Center for Neuroscience at University of Colorado Boulder. ? Her research focuses on neuroplasticity in hearing loss and has been funded by the United States National Institutes of Health for over two decades. She has over 75 scientific publications and has given over 200 invited presentations and keynotes on her research. She has given the Carhart Memorial Lecture at the AMERICAN AUDITORY SOCIETY, the Marion Downs Lecture twice at the American Academy of Audiology and the Ted Evans Lecture at the The British Society of Audiology. ? During her keynote, Anu Sharma will shed light on neuroplasticity in hearing loss. Hearing loss results in both structural and functional changes in the brain. Adults and children with hearing loss who receive intervention with hearing aids and cochlear implants provide a platform to examine the trajectories and characteristics of deprivation-induced and experience-dependent plasticity in the central auditory system. Cross-modal neuroplasticity in children with bilateral cochlear implants, single-sided deafness and adults with mild-moderate age-related hearing loss and cortical re-organization in age-related hearing loss will be discussed. Importantly, if cross-modal plasticity is harnessed appropriately, or reversed with appropriate hearing treatments, it can result in good clinical outcomes coinciding with gains in cognitive performance and speech perception. By harnessing neuroplasticity, brain-based biomarkers are developed. These biomarkers can help clinicians determine when a patient should receive intervention, what kind of intervention or rehabilitation would be ideal, and may offer the ability to monitor how well a chosen intervention or rehabilitation method is working. Biomarkers may help us to predict which patients may perform well with hearing aids or cochlear implants—and, importantly, which patients will need additional support in the form of personalized aural rehabilitation programs or brain training.?Brain-based biomarkers may eventually help revolutionize how we treat and manage patients with hearing loss. ? More information about the program soon: (eaono2024.org) ?